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Abstract 
Background: Pseudomonas aeruginosa has emerged as a significant opportunistic bacterial pathogen that causes nosocomial 
infections in healthcare settings resulting in treatment failure throughout the world. This study was carried out to compare 
the relatedness between virulence characteristics and β-lactamase encoding genes producing Pseudomonas aeruginosa. 
Methods: A total of 120 P. aeruginosa isolates were obtained from both paediatric and adult patients of Selayang Hospital, 
Kuala Lumpur, Malaysia. Phenotypic methods were used to detect various virulence factors (Phospholipase, Hemolysin, 
Gelatinase, DNAse, and Biofilm). All the isolates were evaluated for production of extended spectrum beta-lactamase 
(ESBL) as well as metallo β-lactamase (MBL) by Double-disk synergy test (DDST) and E-test while AmpC β-lactamase 
production was detected by disk antagonism test.  
Results: In this study, 120 Pseudomonas aeruginosa isolates (20 each from blood, wounds, respiratory secretions, stools, 
urine, and sputum samples) were studied. Among Pseudomonas aeruginosa isolates, the distribution of virulence factors was 
positive for hemolysin (48.33%), DNAse (43.33%), phospholipase (40.83%), gelatinase (31.66%) production and biofilm 
formation (34%) respectively. The prevalence of multiple β-lactamase in P. aeruginosa showed 19.16% ESBL, 7.5% MBL 
and 10.83% AmpC production respectively. 
Conclusion: A regular surveillance is required to reduce public health hazard and the spread of virulence factors and β-
lactamase genes among clinical isolates of Pseudomonas aeruginosa  
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1. INTRODUCTION 
       
The widespread expansion of Pseudomonas 
aeruginosa resistant strains is due to exploitation and 
mistreatment of antibiotics which generates several 
bacterial virulences.  
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Antibiotics play a vital role against pathogenic 
bacteria, but studies have shown that antibiotics to be 
less effective against bacteria with different virulence 
factors. The improvement and innovation of 
antimicrobials agents with novel or unexplored 
properties are becoming an increasing need to control 
and manage bacterial infectious diseases effectively. 
Pseudomonas aeruginosa is opportunistic pathogenic 
bacteria, causes numerous infection. P. 
aeruginosa releases various types of virulence factors, 
and the pathogenesis is linked with several cell-
associated and extracellular factors which are 
responsible for the severe therapeutic problem 
(Alireza Mohammadzadeh, Jalal Mardaneh, Reza 
Ahmadi, & Javad Adabi, 2017). Infectious diseases 
caused by P. aeruginosa are problematic to treat due 
to the resistance development and produce multiple 
virulence factors (Pereira, Rosa, & Cardoso, 2015).  In 
the hospital, commonly caused nosocomial infection 
particularly in immunosuppressed, burns and cystic 
fibrosis patients are due to Pseudomonas aeruginosa. 
Severe infections with high mortality are problematic 
to treat and often failure treatment. The high 
percentage of mortality and its multidrug resistance 
mechanism has driven P. aeruginosa as an emerging 
superbug (Khan & Khan, 2016; Tanwar, Das, Fatima, 
& Hameed, 2014). Virulence factors modify the 
immune system by adhesion, evading and destroying 
the tissues for the progression of diseases 
(Moghaddam, Khodi, & Mirhosseini, 2014). 
 
P. aeruginosa possesses many virulence factors 
(A. Mohammadzadeh, J. Mardaneh, R. Ahmadi, & J. 
Adabi, 2017; Sánchez-Diener et al., 2017; Ullah, 
Qasim, Rahman, Jie, & Muhammad, 2017). 
Pseudomonas aeruginosa is widely distributed and 
able to secrete multiple virulence factors such as 
hemolysin, gelatinase, DNAase and produce biofilm 
(Pramodhini, Umadevi, & Seetha, 2016). These 
factors are damaging their host’s immune systems and 
form a barrier to antibiotics that reduce antibiotic 
efficiency resulting in treatments to be incompetent 
and failure. Numerous virulence factors of P. 
aeruginosa can cause acute and chronic infections 
(Sánchez-Diener et al., 2017). Several extracellular 
virulence factors are liable for blood steam invasion, 
diffusion, and tissue damage after colonization 
(Sonbol, Khalil, Mohamed, & Ali, 2015). Hemolysin 
and protease are known to be important virulence 
factors of P. aeruginosa. The formation of hemolysin 
production in Pseudomonas aeruginosa is dependent 
on the isolates specimens and antigenic structure 
(Kamel, Edeen, Yousef El-Mishad, & Ezzat, 2011). 
Gelatinase is a group of protease which can hydrolyze 
gelatine into a polypeptide, amino acid, and peptides 
(Balan, Nethaji, Sankar, & Jayalakshmi, 2012). DNase 
degrades the extracellular DNA to be weak and 
susceptible to microorganisms (Sharma & Pagedar 
Singh, 2018). Biofilm formation in P. 
aeruginosa reduces the efficacy of antibiotic 
sensitivity, and metabolic rate (Mulcahy, Isabella, & 
Lewis, 2014) but enhance efflux (Alav, Sutton, & 
Rahman, 2018). In biofilm producing 
microorganisms, antimicrobial resistance is much 
higher than the planktonic cell (Pagedar & Singh, 
2012). The prevalence of extended spectrum-β-
lactamases (ESBL), Metallo β-lactamase (MBL) and 
AmpC producing Pseudomonas aeruginosa 
distinguishing virulence factors which may have 
effects on prolonging treatment and effective control.  
The principle of this work was to assess the 
significant association among the virulence factors, 
and β-lactamase mechanisms and their antimicrobial 
resistance of Pseudomonas aeruginosa 
 
2. MATERIALS AND METHODS 
 
For this study, 120 P. aeruginosa isolates of both 
paediatric and adult patients were obtained from six 
various types of clinical samples such as blood, 
wounds, respiratory secretions, stools, urine, and 
sputum at Selayang Hospital, Kuala Lumpur, 
Malaysia. 
 
Antibiotic sensitivity test  
 
A routine antimicrobial susceptibility test was 
performed for Pseudomonas aeruginosa (120) by 
Kirby-Bauer disk diffusion standard method. The 
inoculated bacterial colonies were incubated overnight 
at 37 ºC. In this study, we have used ten commonly 
prescribed different types of antibiotics such as 
tazobactam 10/ piperacillin 75- TZP, ciprofloxacin-
CIP, imipenem-IPM, cefepime-FEP, cefotaxime -
CTX, aztreonam – ATM, amoxicillin-clavulanic acid 
– AMC, ceftazidime-CAZ, cefoperazone -CPZ and 
meropenem-MEM.  The results were recorded by 
measuring the inhibition zone as sensitive, 
intermediate, and resistant (R), following CLSI 
guidelines. As a quality control, we have used P. 
aeruginosa ATCC 27853. 
 
Detection of hemolysin  
 
For the detection of hemolysins, bacterial isolated 
colonies were plated on plates (Sheep blood agar 5%) 
for 24 hours at 37ºC. After incubation, total lysis of red 
blood cells (clear zone) formed surrounding the 
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cultured colonies which indicated as positivity for 
hemolysins. 
 
Detection of phospholipase  
 
The nutrient agar media for detection of 
phospholipase was inoculated with a bacterial colony 
for overnight incubation at 37 ºC culture. Formation of 
bacterial colonies from white to brown color 
considered as a positive result. 
 
Detection of gelatinase  
 
The gelatinase production was studied onto 
nutrient gelatin agar medium containing 1% 
concentrated bacterial culture. The cultured plates kept 
for incubation at 37 °C for up to 7 days. Formation of 
precipitation (an opaque) zone surrounding the spot 
indicated positivity for proteases. 
 
Detection of DNAse activity  
 
DNase test agar plates were used in this test to 
grow the bacterial colonies for 24 to 48 hours at 37°C. 
HCl/1N solution (one drop) was added to the spotted 
cultures and a clear zone formation around the culture 
indicated as positive for DNAse reaction. 
 
Detection of Biofilm production (tube 
adherence method)   
 
Tube method is commonly used for biofilm 
detection. In our study, five bacterial colonies were 
inoculated to 5ml of BHI broth in glass tubes and kept 
for incubation at 37°C for 20 hrs. The cultures were 
suctioned after incubation and saffranine mixed to 
stains of the test tubes. The visible film growth on the 
wall of the tube indicated as positivity for biofilm. 
Extended-spectrum beta-lactamase (ESBL), 
AmpC beta-lactamase and Metallo β-lactamase 
(MBL) genes were detected to find out the 
antimicrobial mechanisms of Pseudomonas 
aeruginosa by the following methods. 
 
Detection of Extended spectrum-β-lactamase 
(ESBL) and Metallo β-lactamase (MBL) 
 
One hundred twenty isolates of Pseudomonas 
aeruginosa were studied to detect the presence of 
(ESBL and MBL) β-lactamase genes by two most 
established methods, Double-disk synergy test 
(DDST) and E-test. In DDST, a cephalosporins (third 
generation antibiotic) disc and augmentin (penicillin 
combination) disc were placed 30mm apart from 
center to center on Muller-Hinton Agar (MHA). A 
perfect clear zone of inhibition zone around the 
cephalosporin to augmentin disc was identified for 
positivity for ESBL gene.  
The phenotypic confirmatory test was used 
among the isolates of Pseudomonas aeruginosa for 
ESBL production. Briefly, a 0.5 MacFarland's 
suspension of P. aeruginosa was spread on a Muller – 
Hinton agar (MHA) plate and ceftazidime 30 μg (third 
generation- cephalosporins) disc and ceftazidime 30 
μg / clavulanic acid 10 μg (cephalosporins 
combinations) disc were positioned on the MHA plate. 
Two discs were placed on the MHA plate with a 
distance of 15mm in between and kept for overnight 
incubation at 37°C. Formation of a clear zone of a ≥ 
5mm size for the combined discs compared to 
cefotaxime or ceftazidime disc alone established the 
presence of ESBL producing an organism. Expansion 
of zone diameter is a consequence of inhibition of the 
β-lactamase by clavulanic acid (Thomson, Ayaz, 
Lutes, & Thomson, 2018). To screen MBL producing 
Pseudomonas aeruginosa strains we have used EDTA, 
extra pure powder. The inhibition zones of imipenem 
and imipenem-EDTA disc formed an inhibition zone 
around them after 24 hours of incubation at 37˚C. The 
zone of inhibition ≥7mm with imipenem and EDTA 
disk than imipenem disk alone was detected as MBL 
producing organisms. Manufacturer's instructions 
were strictly followed for the E-test for detection of 
ESBL and MBL producers. 
 
Detection of AmpC beta-lactamase by disk 
antagonism test  
 
Disk antagonism test was used to detect inducible 
AmpC β lactamase among the isolates of 
Pseudomonas aeruginosa. A 0.5 McFarland 
suspension of bacterial colonies were plated over a 
Mueller Hinton agar (MHA) plate. Cefotaxime 30μg 
(cephalosporins- third generation) and cefoxitin 30μg 
(cephalosporins- second generation) discs were kept 
20mm apart from center to center, and the result was 
observed after overnight incubation at 37°C. AmpC β-
lactamase producing isolates were identified by the 
formation of a blunting inhibition zone of cefotaxime 
adjacent to cefoxitin (Supriya Upadhyay, Sen, & 
Bhattacharjee, 2010). AmpC disc test was performed 
for confirmation of AmpC producing strains. 
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3. RESULTS 
One hundred and twenty strains of Pseudomonas 
aeruginosa from six different source (wounds, urine, 
stools, sputum, respiratory and blood) of clinical 
samples were used in this study. The percentage of the 
distribution pattern of Pseudomonas aeruginosa in 
clinical samples is shown in Table 1. 
Antimicrobial susceptibility test was done against 
10 different types of antibiotic commonly prescribed 
for the Pseudomonas aeruginosa infections. Among 
the different types of antibiotics, ciprofloxacin showed 
the highest resistance (38%) followed by ceftazidime 
(35%) then cefepime (31%) and the lowest percentage 
of resistance was shown by cefotaxime (10%) (Figure 
2). 
Forty-nine (40.83%) isolates of Pseudomonas 
aeruginosa showed multidrug resistance. Maximum 
10 different types of antibiotics were resistance to 3 
(2.5%) isolates followed by 6 antibiotics to 7 (5.8%) 
and 3 types of antibiotics to 12 (10%) strains of 
Pseudomonas aeruginosa (Table 2). 
Virulence factors play an essential role in 
antimicrobial resistance. In our study, 48.33% isolates 
were positive for hemolysin followed by 43.33% 
DNAse, 40.83% phospholipase, 31.66% gelatinase 
and 17.5% biofilm producer. 
 
Some virulence factors of β-lactamase were 
observed in 120 clinical strains of Pseudomonas 
aeruginosa in our study. Among all the isolates, 
19.16% were ESBL isolates followed by 10.83% 
AmpC, and 7.5% MBL producers. A total number of 
49 (40.83%) isolates were multidrug resistance 
(Figure 4). The observation of both these tests is 
shown in figure 5. 
An analysis of the association between virulence 
factors and β-lactamase were performed among all the 
clinical isolates of Pseudomonas aeruginosa (Table 
3). We have found that there was a significant 
association among hemolysin (p-value- 0.02), 
phospholipase (p-value-0.03), and DNAse (p-value-
0.005) in ESBL producers. The MBL producing 
isolates showed the association with hemolysin (p-
value-0.009), gelatinase (p-value-0.0001), and biofilm 
(p-value-0.02). AmpC producing virulence factors 
revealed a correlation among gelatinase (p-value- 
0.00001), DNAse (p-value-0.009), and biofilm (p-
value-0.003). We have considered the association to 
be positive if the p-value is below (p<0.05). We have 
observed the association between virulence factors 
and β-lactamase producing isolates in our study (Table 
3). 
4. DISCUSSIONS 
 
Severe nosocomial infections are commonly 
caused by Pseudomonas aeruginosa. A leading cause 
of broad-spectrum infection especially in respiratory, 
urinary tracts, wounds infections and gastrointestinal 
is due to P. aeruginosa. The pathogenicity of 
Pseudomonas aeruginosa is attributable to the 
production of multiple virulence factors. Infections 
caused by Pseudomonas aeruginosa is difficult to 
eliminate because of its poor efficacy of antibiotics 
and numerous resistance mechanisms by the 
bacterium (Tran et al., 2014). Some previously 
published study has reported that the virulence factors 
are correlated to antibiotic resistance (Roux et al., 
2015) and the presence of high level of virulence 
factors enhance antibacterial resistance (Finlayson & 
Brown, 2011). 
 A total of 120 Pseudomonas aeruginosa were 
isolated from six different types of clinical sources 
(stools, wounds, respiratory, urine, sputum, and blood) 
and their prevalence was analyzed according to sex, 
age group, and clinical sources of the samples. Among 
the clinical isolates, the occurrence rate of 
Pseudomonas aeruginosa was higher at the age group 
of 31-45 in both male and female. In contrast, the 
lowest occurance (10%) was observed at the age group 
of above 60 years (Table 1). According to both sex and 
age, the differences were shown in the frequency of 
isolation between males and females. 
In this study, Quinolone (antibiotics) showed the 
highest resistance (Figure 1) which is similar to our 
another study (Fazlul, Zaini, Rashid, & Nazmul, 2011) 
followed by cephalosporins groups of antibiotics 
which are agreeing to another recent study 
(Senthamarai, 2014). Disk diffusion method was used 
for antibiotic susceptibility test (Figure 2).  Forty-nine 
(40.83%) isolates were positive for multidrug-resistant 
while another recent study has shown that 95.8% 
strains are multidrug-resistant (MDR) (Table 2). The 
ability of virulence factors significantly associated 
with multidrug resistance (MDR) (Finlayson & 
Brown, 2011). It was revealed in some studies that 
virulence factors and multi-drug resistant (MDR) are 
significantly associated (Bradbury, Roddam, Merritt, 
Reid, & Champion, 2010; Deptuła & Gospodarek, 
2010; Finlayson & Brown, 2011).  
The Pathogenicity of P. aeruginosa containing 
several structural components, toxins, and enzymes 
play an essential role in forming infectious diseases 
(Murray, Rosenthal, & Pfaller, 2015). In our study, 
Pseudomonas aeruginosa from different types of 
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clinical samples produces various types of virulence 
factors. We have observed that the highest 48.33% 
activity for hemolysin, 43.33% were positive for 
DNAse, 40.83% positivity for phospholipase, and 
31.66% positivity for gelatinase. In contrast, the 
lowest 17.5% positivity for biofilm production was 
observed (Figure 3). In our study, the observed 
virulence factors in P. aeruginosa is lower compared 
to another similar study reported that the positivity for 
hemolysin was 95.2%, phospholipase 81% and 
gelatinase 78% (Khalil, Sonbol, BADR, & ALI, 
2015). Interestingly, Pramodhini and her colleague 
found hemolysin (80.3%), phospholipase (70%) and 
gelatinase (71.4%) isolates producer (Pramodhini et 
al., 2016). Among the virulence factors, phospholipase 
was detected in 87.5% isolates, 68.75% isolates were 
biofilm producer, and 81.25% strains were detected as 
gelatinase positive (Mohammad, 2013) which were 
much higher compared to our study. 
The lowest percentage of hemolysin (30%) 
activity was recorded in the blood whereas DNAse 
(25%) in respiratory. Among all the different sources 
of clinical samples, urine produced the lowest 
phospholipase (25%), gelatinase (15%) and biofilm 
(5%) respectively. The highest occurrence was 
observed for hemolysin (65%) from stool followed by 
60% for phospholipase, gelatinase, DNAse in blood, 
respiratory, and urine respectively (Figure 3). 
P. aeruginosa developed its resistance to antibiotics 
mostly by the occurrence of plasmid-mediated AmpC 
β-lactamase, extended-spectrum β-lactamases 
(ESBLs) and Metallo-β-lactamases (MBLs) 
(Farshadzadeh, Khosravi, Alavi, Parhizgari, & 
Hoveizavi, 2014). All the β-lactamases producing 
strains were revised for the occurrence of several 
virulence factors. Clinical isolates of ESBL producing 
Pseudomonas aeruginosa under constructive 
condition express its virulence factors and their 
association is significant (Khalil et al., 2015; 
Mansouri, Norouzi, Moradi, & Nakhaee, 2011). A 
recent study reported that plasmid-mediated AmpC 
production in Pseudomonas aeruginosa becomes a 
new risk in the healthcare management of infection (S 
Upadhyay, Mishra, Sen, Banerjee, & Bhattacharjee, 
2013). Among the 120 isolates of Pseudomonas 
aeruginosa, the highest 19.16% strains were ESBL 
positive, MBL (7.5%) and 10.83% were AmpC 
producers (Figure 4). In a recent study, 25.13% 
isolates were ESBL positive (Shaikh, Fatima, Shakil, 
Rizvi, & Kamal, 2015) which is slightly higher 
compare to our result while 19% (NagKumar et al., 
2015), and 18.37% (Sachdeva, Sharma, & Sharma, 
2017) isolates were MBL producers in Pseudomonas 
which are in agreement with our study. Feglo et al. 
(2016) (Feglo & Opoku, 2014) reported 38.0% isolates 
were AmpC positive while it was 10.83% positivity in 
our study. The observation of β-lactamase producing 
Pseudomonas aeruginosa was shown in Figure 5. We 
have observed, virulence factors and β-lactamase 
producers showed a significant association based on 
Pearson's correlation coefficient analysis. According 
to our result, a strong correlation between ESBL 
producing isolates (19.16%) and virulence factors 
(hemolysin, phospholipase, and DNAse) was 
observed. MBL producing strains (7.5%) acted to be 
more expressive with hemolysin, gelatinase and 
biofilm and AmpC producing isolates (10.83%) are 
highly correlated with a phospholipase, gelatinase, 
DNAse, and biofilm respectively. Standard 
significance difference was measured by the p<0.05 
value. No significance was observed among ESBL 
producing a strain with gelatinase and biofilm factors, 
MBL producing isolates with phospholipase and 
DNAse respectively, and AmpC strains with 
hemolysins (Table 3). 
 
In most of the research, resistance 
mechanisms and virulence factors have studied 
separately, but there are a few research which showed 
the biological association. Pearson’s correlation 
coefficient ((p<0.05) was used to find out the 
significant association between virulence factors and 
β lactamase producers. Varying environmental 
conditions can enhance the expression of virulence 
factors in P. aeruginosa. Besides, cell signaling 
pathways regulate the expression of virulence factors 
(Ullah et al., 2017). Moreover, effective correlation is 
present among the secretion of virulence factors and 
beta-lactamase producing Pseudomonas aeruginosa 
(Khalil et al., 2015). We could be established that 
antimicrobial sensitivity of P. aeruginosa depends on 
the microbial biological correlation among virulence 
factors and source of isolations. 
 
5. CONCLUSIONS 
This study revealed that the exhibits of virulence 
factors and the beta-lactamase producers from various 
infections sites have a strong antimicrobial resistance 
against different groups of antibiotics and the 
pathogenesis worsen in healthcare management. From 
the evaluated data on hemolysin, protease, 
phospholipase, DNAse, biofilm formation and 
lactamase among the Pseudomonas aeruginosa 
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isolates, an association between the multidrug 
resistance and pathogenesis are more prominent was 
observed.  Therefore, this study highlights the effect of 
the correlation between the source of infections and 
virulence factors must be periodically monitored to 
understand possible mechanisms.  The information 
and the recommendation of this study will improve to 
control these infections, development of alternative 
therapy and therapeutic success in the community.  
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Table 1: Frequency of Pseudomonas aeruginosa from different clinical samples collected based on sex, age and sources 
Age 
Groups in 
Years 
Gender Total 
(%) 
Sources of clinical isolates (120) 
Male Female 
S
to
o
l 
W
o
u
n
d
s 
R
esp
irato
r
y
 
U
rin
e 
S
p
u
tu
m
 
B
lo
o
d
 
1-15  13 6 15.83 5 3 5 2 2 2 
16-30  17 9 21.67 3 2 5 5 4 7 
31-45 25 15 33.33 9 10 5 6 6 4 
46-60 12 11 19.17 2 4 2 6 4 5 
Above 60 8 4 10 1 1 3 1 4 2 
 
 
Table 2: Multi-drug resistance among the Pseudomonas aeruginosa isolates (120) 
No of antibiotics Types of antibiotics No (%) of MDR                         
P. aeruginosa isolates 
3 classes of antibiotics CTX, TZP, IMP 12 (10%) 
4 classes of antibiotics ATM, MEM, CIP 17 (14.1%) 
5 classes of antibiotics MEM, AMC, FEP, CAZ, CTX 10 (8.3%) 
6 classes of antibiotics AMC, CTX, ATM, IMP, CIP, CPZ 7(5.8%) 
10 classes of antibiotics TZP, CAZ, CIP, MEM, IMP, FEP, CTX, 
ATM, AMC, CPZ 
3(2.5%) 
 Total 49(40.83%) 
 
Table 3: Analysis of the association between virulence factors and β-lactamase producers 
  Hemolysin Phospholipase Gelatinase DNAse Biofilm 
  
Positi
ve  
Negati
ve 
Positi
ve 
Negati
ve 
Positi
ve 
Negati
ve 
Positi
ve  
Negati
ve 
Positi
ve 
Negati
ve  
Esbl 
Positiv
e (23) 6 16 5 18 8 15 4 19 6 17 
Negati
ve (97) 52 46 44 53 30 67 48 49 15 82 
 P-value 0.02  0.03  0.07  0.005  0.2  
MBL 
Positiv
e (9) 8 1 5 4 8 1 3 6 4 5 
 
Negati
ve 
(113) 50 63 44 69 30 83 49 64 17 96 
 P-value 0.009  0.3  0.0001  0.5  0.02  
Amp
C 
Positiv
e (13) 3 10 9 4 11 2 10 3 6 7 
 
Negati
ve 
(107) 55 52 40 67 27 80 42 65 15 92 
 P-value 0.05  0.02  
0.0000
1  0.009  0.003  
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Figure 1: Antibiotic susceptibility test by disk diffusion method 
 
 
Tazobactam 10/ piperacillin 75- TZP, ciprofloxacin-CIP, imipenem-IPM, cefepime-FEP, cefotaxime -CTX, 
aztreonam – ATM, amoxicillin-clavulanic acid – AMC, ceftazidime-CAZ, cefoperazone -CPZ and meropenem-MEM. 
 
Figure 2: Analysis of antibiotic susceptibility test 
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Figure 3: Virulence factors production from different clinical sources 
 
 
 
Figure 4: ESBL, MBL, AmpC production and multidrug resistance among the isolates (n=120) 
 
  
Figure 5: Detection of ESBL and MBL test 
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